|52.51||-0.92 / -1.72%|
Data as of 4:00pm ET
|57.50||+4.99 / +9.50%|
The 5 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 59.00, with a high estimate of 60.00 and a low estimate of 42.00. The median estimate represents a +12.36% increase from the last price of 52.51.
The current consensus among 5 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.